Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Bio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...

OpenAI CEO Sam Altman's significant investments in companies doing business with his AI firm have come under scrutiny. Court documents reve...

Happy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...

Investors are prioritising smaller, early-stage deals in deeptech sectors like AI, healthcare, and precision manufacturing, shying away fro...

Indian markets closed lower amid selling in financial, consumer and realty stocks, with Nifty and Sensex declining. Technical indicators si...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

Shares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...

Amazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...

“Any vaccine is a biological product and has to be produced with the utmost precaution of biosafety,” Sandeep Rathod, CEO of Haffkine Bio-P...

New Delhi, May 17 (IANS) The Cabinet Committee on Economic Affairs (CCEA) on Wednesday approved a collaborative mission between industry an...

The 'Innovate in India empowering biotech entrepreneurs and accelerating inclusive innovation' mission will strengthen domain specific know...

"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."

Earlier in 2013, the Hyderabad-based company launched its patented arthiritis management product, Cadalmin GAe.

Incoming Modi-led govt represents an 'excellent opportunity' for American industries to strengthen & rekindle their relationships with Indi...

India has emerged as a global leader in vaccines with about one-third share of the total market, a senior government official said today.

Pharmaceutical firm Cadila Healthcare will set up a bio-technology plant here with an investment of Rs 25 crore for manufacturing biosimila...